Back to Search
Start Over
Reports Summarize P2Y12 Platelet Inhibitors Study Results from Aarhus University Hospital (Real-World Experience with Cangrelor as Adjuvant to Percutaneous Coronary Intervention: A Single-Centre Observational Study).
- Source :
- Clinical Trials Week; 7/4/2023, p968-968, 1p
- Publication Year :
- 2023
-
Abstract
- Cangrelor Therapy, Drugs and Therapies, P2Y12 Platelet Inhibitors, P2Y12 Receptor Antagonists, Pharmaceuticals, Risk and Prevention Keywords: Cangrelor Therapy; Drugs and Therapies; P2Y12 Platelet Inhibitors; P2Y12 Receptor Antagonists; Pharmaceuticals; Risk and Prevention EN Cangrelor Therapy Drugs and Therapies P2Y12 Platelet Inhibitors P2Y12 Receptor Antagonists Pharmaceuticals Risk and Prevention 968 968 1 07/03/23 20230704 NES 230704 2023 JUL 3 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Investigators discuss new findings in P2Y12 platelet inhibitors. [Extracted from the article]
Details
- Language :
- English
- ISSN :
- 15436772
- Database :
- Complementary Index
- Journal :
- Clinical Trials Week
- Publication Type :
- Periodical
- Accession number :
- 164630045